ORPEA

6 acquisitions in Europe: 4,713 beds in 3 countries - Seite 2

The acquisition of Sensato AG perfectly matches ORPEA's value creation criteria:

• a reputation for quality and excellence in care;
• modern buildings, built less than 5 years ago and in excellent locations;
• almost a third of the network is in the roll-out phase, thus offering significant potential for increasing business volume and optimising operational performance.

In 2020, Sensato AG posted revenue of €20 million. It has been consolidated since 1 May 2021.

Thanks to this acquisition, ORPEA has strengthened its position as the second largest player in Switzerland with a total network of 47 facilities and 4,367 beds.

Spain: strengthening of the global care offering in three business segments with the acquisition of Hestia Alliance and seven Sanitas facilities

Hestia Alliance Group, founded in 1992, offers a comprehensive range of post-acute care, palliative care, long stays and mental health services in 14 facilities, 60% of which are located in Madrid and Barcelona and 14% in the Balearic Islands. The Hestia network, one of the largest in the country with 2,131 beds, has an excellent reputation for quality care and offers strong complementarity with the ORPEA network in Spain. The management team will remain linked to the Group and will continue to share its know-how and experience with ORPEA in Spain.

Hestia posted revenue of €70 million in 2020. As part of this transaction, ORPEA has also acquired 7 buildings. Hestia² will be consolidated at the end of 2021 or, at the latest, in early 2022.

This acquisition thus significantly strengthens ORPEA’s positioning in the post-acute care and rehabilitation and mental health sectors in Spain and provides a new development platform for these activities, for which there is a growing need.

In addition, ORPEA has acquired 7 facilities (838 beds) from Sanitas, a subsidiary of Bupa, a British health insurance and care group, which will complete the Group's current network of Premium nursing homes. Two of these facilities are open (188 beds) and five are under construction and redeployment in Madrid, Barcelona, Logrono and San Sebastian, representing total potential revenue of €25m at maturity.

Upon completion of these two operations, ORPEA will be active in the Spanish market with its three complementary business segments, operating 87 facilities representing 14,300 beds.

6 value-creating acquisitions representing more than 4,700 beds and over €210 million in revenue

These six acquisitions perfectly illustrate the uniqueness of the Group's external growth strategy. They perfectly complement the geographical network and the care pathway in the various countries and have common characteristics, namely: